SJ

Suresh Jagannath Bagal

Active Director Director DIN 09026798
DIN 09026798 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Suresh Jagannath Bagal

Data last updated:

Suresh Jagannath Bagal is a Director at Glosmit Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Glosmit Pharmaceutical Private Limited reported revenue of ₹8.2 Lakh (FY 2024).

DIN 09026798
Primary Designation Director
Industry Pharma
First Appointment 12 Jan 2021
Oldest Company Age 5 yrs
Largest company Glosmit Pharmaceutical Private Limited · ₹8.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jan 20212021₹8.2 Lakh (FY 2024)Active

Board colleagues of Suresh Jagannath Bagal

NameDINCompanyDesignation
Deepak Suresh Bagal09026797Glosmit Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Glosmit Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Suresh Jagannath Bagal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Jagannath Bagal

Suresh Jagannath Bagal currently holds 1 directorship: Glosmit Pharmaceutical Private Limited (Director, since 12 Jan 2021, revenue ₹8.2 Lakh (FY 2024)).

Suresh Jagannath Bagal was first appointed on 12 Jan 2021 as Director at Glosmit Pharmaceutical Private Limited.

The current boards of Suresh Jagannath Bagal's companies include Deepak Suresh Bagal (Glosmit Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available